Clinical Trial Update: Gender-Based Differences in Heart Failure Hospitalizations Among Patients With Heart Failure Treated With Spironolactone

View source ↗

Summary

A completed clinical trial examining gender-based differences in heart failure hospitalizations among patients treated with spironolactone.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• Aldactone (spironolactone)

Snippet

Sponsor: Ahmad Abdullah Salawi | Conditions: Heart Failure, Heart Failure With Reduced Ejection Fraction | Status: COMPLETED